Clara Montagut is Head of the Gastrointestinal Cancer Unit and leads a team of clinical and translational research in novel therapies and biomarkers in colorectal cancer at Hospital del Mar Research Institute in Barcelona, Spain. Dr Montagut is also Professor at the Pompeu Fabra University in Barcelona.
Clara Montagut graduated in Medicine and Surgery from the Universitat Autònoma de Barcelona (1999) and obtained her specialization in Medical Oncology at Hospital Clínic de Barcelona (2004). She completed her training at the Massachusetts General Hospital Cancer Center – Harvard School of Medicine in Boston (J. Settleman lab). On her return from the United States in 2009, she defended her doctoral thesis on resistance to targeted therapy in cancer (Universitat de Barcelona, excellent cum laude) and joined the Medical Oncology Department at Hospital del Mar in Barcelona. In 2017-2018 she did a fellowship at Memorial Sloan Kettering Cancer Center, New York, on liquid biopsy in gastrointestinal malignancies (L.A. Diaz lab).
Dr. Montagut is leading and has participated in a large number of national and international trials in gastrointestinal cancer, has more than 100 publications in prestigious top journals, and 2 licensed patents. Dr. Montagut is faculty member of the ESMO Scientific Committee in lower GI tumors, as well as the board of directors of the Spanish group of digestive tumors (TTD). She is the President of the Scientific Committee for evaluation of national grants from the Spanish Ministry of Health.